The Revolution in Treatment of Hepatitis C

Jordan Mayberry, William M Lee

Research output: Contribution to journalReview article

Abstract

Treatment of hepatitis C with interferon therapy produced some cures early on, but was associated with significant side effects. Because of further advances in the molecular understanding of hepatitis C, by 2014 effective treatments became available that far surpassed all prior interferon-based regimens in efficacy, tolerability, and safety. This led to rapid transformation of a hard-to-treat disease to simple, safe, and effective treatment offered to anyone. This article focuses on hepatitis C epidemiology; the clinical impact and consequences; discussion of past hepatitis C treatments; and a review of current recommendations for screening, diagnosis, and treatment of this ubiquitous virus.

LanguageEnglish (US)
Pages43-55
Number of pages13
JournalMedical Clinics of North America
Volume103
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Hepatitis C
Interferons
Epidemiology
Viruses
Safety
Therapeutics

Keywords

  • Direct-acting antivirals
  • Hepatitis C virus
  • Polymerase inhibitors
  • Protease inhibitors
  • Sustained viral response

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The Revolution in Treatment of Hepatitis C. / Mayberry, Jordan; Lee, William M.

In: Medical Clinics of North America, Vol. 103, No. 1, 01.01.2019, p. 43-55.

Research output: Contribution to journalReview article

Mayberry, Jordan ; Lee, William M. / The Revolution in Treatment of Hepatitis C. In: Medical Clinics of North America. 2019 ; Vol. 103, No. 1. pp. 43-55.
@article{6059cc75833343f4a02aac21dfb3f833,
title = "The Revolution in Treatment of Hepatitis C",
abstract = "Treatment of hepatitis C with interferon therapy produced some cures early on, but was associated with significant side effects. Because of further advances in the molecular understanding of hepatitis C, by 2014 effective treatments became available that far surpassed all prior interferon-based regimens in efficacy, tolerability, and safety. This led to rapid transformation of a hard-to-treat disease to simple, safe, and effective treatment offered to anyone. This article focuses on hepatitis C epidemiology; the clinical impact and consequences; discussion of past hepatitis C treatments; and a review of current recommendations for screening, diagnosis, and treatment of this ubiquitous virus.",
keywords = "Direct-acting antivirals, Hepatitis C virus, Polymerase inhibitors, Protease inhibitors, Sustained viral response",
author = "Jordan Mayberry and Lee, {William M}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.mcna.2018.08.007",
language = "English (US)",
volume = "103",
pages = "43--55",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The Revolution in Treatment of Hepatitis C

AU - Mayberry, Jordan

AU - Lee, William M

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Treatment of hepatitis C with interferon therapy produced some cures early on, but was associated with significant side effects. Because of further advances in the molecular understanding of hepatitis C, by 2014 effective treatments became available that far surpassed all prior interferon-based regimens in efficacy, tolerability, and safety. This led to rapid transformation of a hard-to-treat disease to simple, safe, and effective treatment offered to anyone. This article focuses on hepatitis C epidemiology; the clinical impact and consequences; discussion of past hepatitis C treatments; and a review of current recommendations for screening, diagnosis, and treatment of this ubiquitous virus.

AB - Treatment of hepatitis C with interferon therapy produced some cures early on, but was associated with significant side effects. Because of further advances in the molecular understanding of hepatitis C, by 2014 effective treatments became available that far surpassed all prior interferon-based regimens in efficacy, tolerability, and safety. This led to rapid transformation of a hard-to-treat disease to simple, safe, and effective treatment offered to anyone. This article focuses on hepatitis C epidemiology; the clinical impact and consequences; discussion of past hepatitis C treatments; and a review of current recommendations for screening, diagnosis, and treatment of this ubiquitous virus.

KW - Direct-acting antivirals

KW - Hepatitis C virus

KW - Polymerase inhibitors

KW - Protease inhibitors

KW - Sustained viral response

UR - http://www.scopus.com/inward/record.url?scp=85056792880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056792880&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2018.08.007

DO - 10.1016/j.mcna.2018.08.007

M3 - Review article

VL - 103

SP - 43

EP - 55

JO - Medical Clinics of North America

T2 - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 1

ER -